Next Article in Journal / Special Issue
Ethnopharmacological Study of Medicinal Plants Used for the Treatment of Cardiovascular Diseases and Their Associated Risk Factors in sub-Saharan Africa
Previous Article in Journal
Role of Spermidine in Photosynthesis and Polyamine Metabolism in Lettuce Seedlings under High-Temperature Stress
Previous Article in Special Issue
Ethnobotanical Survey of Local Flora Used for Medicinal Purposes among Indigenous People in Five Areas in Lagos State, Nigeria
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Plants
Volume 11
Issue 10
10.3390/plants11101386
plants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Helichrysum Genus and Compound Activities in the Management of Diabetes Mellitus

by
Akeem O. Akinfenwa
1,
Idowu J. Sagbo
1,*,
Masixole Makhaba
2,
Wilfred T. Mabusela
2 and
Ahmed A. Hussein
1,*
1
Chemistry Department, Cape Peninsula University of Technology, Symphony Road, Bellville Campus, Bellville 7535, South Africa
2
Chemistry Department, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa
*
Authors to whom correspondence should be addressed.
Plants 2022, 11(10), 1386; https://doi.org/10.3390/plants11101386
Submission received: 27 March 2022 / Revised: 2 May 2022 / Accepted: 10 May 2022 / Published: 23 May 2022
(This article belongs to the Special Issue Updates on African Traditional Medicinal Plants Research)
Browse Figures
Versions Notes

Abstract

:
The global management of diabetes mellitus (DM) involves the administration of recommended anti-diabetic drugs in addition to a non-sedentary lifestyle upon diagnosis. Despite the success recorded from these synthetic drugs, the traditional method of treatment using medicinal plants is increasingly accepted by the locals due to its low cost and the perceived no side effects. Helichrysum species are used in folk medicine and are documented for the treatment of DM in different regions of the world. This study reviews Helichrysum species and its compounds’ activities in the management of DM. An extensive literature search was carried out, utilizing several scientific databases, ethnobotanical books, theses, and dissertations. About twenty-two Helichrysum species were reported for the treatment of diabetes in different regions of the world. Among these Helichrysum species, only fifteen have been scientifically investigated for their antidiabetic activities, and twelve compounds were identified as bioactive constituents for diabetes. This present review study will be a useful tool for scientists and health professionals working in the field of pharmacology and therapeutics to develop potent antidiabetic drugs that are devoid of side effects.

1. Introduction

Diabetes mellitus is a very prevalent disease affecting both developed and developing countries. Concerted efforts by the International Diabetes Federation (IDF) and the American Diabetes Association (ADA) to reduce the spike in global diabetes cases and mortality have witnessed different advocacies over the past years. The IDF [1] report shows that 463 million (9.3%) adults worldwide are suffering from diabetes, and this number is projected to increase by 51% in 2030 (578 million) and 2045 (700 million). The prevalence of diabetes varies according to geographical region, with more than 80% of diabetic patients living in low-to-middle-income countries, which poses additional challenges with ineffective treatment [2]. Diabetes mellitus is caused by increased blood glucose levels (hyperglycemia) due to defects in insulin action, insulin secretion, or both [3].
The two common types of diabetes (insulin-dependent (type 1) and non-insulin-dependent (type 2)) occur when the body cannot properly store and use glucose. Type 1 is reported to be common in children and is controlled by an autoimmune disorder resulting in a lack of insulin production. Type 2 diabetes is prevalent among adults, characterized by insufficient insulin production and or sensitivity to glucose uptake [4]. Both types of diabetes can lead to life-threatening complications such as neurological conditions, cardiovascular disease, damage to blood vessels, kidney disease, and vision loss [5]. In general, the common symptoms of diabetes mellitus include increased hunger, numbness in hands and feet, frequent urination, excessive thirst, tiredness and fatigue, blurred vision, sores that take long to heal, and sexual dysfunction in men [6]. To date, there is no cure for diabetes; however, several efforts including the use of medicinal plants such as Helichrysum species are continuously targeted to find a permanent treatment for diabetes.

1.1. Conventional Treatment of Diabetes

The conventional treatment of diabetes requires oral administration of synthetic hypoglycemic agents. These synthetic hypoglycemic agents include alpha-glucosidase inhibitors (acarbose and miglitol), insulin secretagogues (meglitinides and sulfonylureas), and insulin sensitizers (thiazolidinediones, biguanides, and metformin), among others that ultimately suppress increasing plasma glucose levels (Figure 1). These drugs are known to function in two distinct ways: (1) during glucose synthesis via enzyme inhibition of glycopolymers breakdown and, (2) insulin bioavailability via the repair of β-cells of the pancreas, thereby improving insulin release and sensitivity for glucose uptake [7]. However, despite the use of these glucose-lowering drugs for the treatment of diabetes, most of these drugs have been reported with negative side effects, such as abdominal pain, headache, dizziness, diarrhea, flatulence, and digestive discomfort [8,9]. In addition, the high cost of these drugs also limits their usage. Hence, there is a need for a cheaper and more efficient drug through the application of natural products from medicinal plants with near-zero side effects [10].

1.2. Medicinal Plants as Alternative Therapies for Diabetes

In line with some drawbacks linked with the use of current glucose-lowering (antidiabetic) drugs, medicinal plants have been reported to play a significant role and serve as alternative therapies for the treatment of diabetes mellitus [11,12,13]. This is mostly due to the presence of several antidiabetic compounds (alkaloid, phenolic, flavonoid, and tannin), thereby improving the ability of pancreatic tissues to enhance insulin secretion or reducing the intestinal absorption of glucose [14]. In addition, the least side effects, ease of availability, and lower cost also make medicinal plants the main key players in the treatment of diabetes. Recently, the number of people with diabetes cases has been growing steadily and causing increasing concerns in most developing countries. Despite the presence of several antidiabetic drugs in the pharmaceutical market, the treatment of diabetes using medicinal plants has been recommended and often successful [15]. In the literature, various research areas have reported the use of medicinal plants and their active components as alternative sources for the treatment of diabetes [16,17]. For example, Salehi et al. [18] reported the antidiabetic of medicinal plants and their active compounds. In the study, the authors described several medicinal plants with anti-diabetic potential. Duarte et al. [19] also reported naturally occurring compounds from different plant extracts exhibiting inhibition of alpha-amylase, alpha-glucosidase, and related enzymes in the management of type II diabetes. Another study by IfedibaluChukwu et al. [20] reported in vivo antidiabetic properties of isolated compounds from the methanol stem bark extract of Vernonia amygdalina using streptozotocin-induced diabetes rats. In the study, it was revealed that the isolated compound (6β, 10β, 14β-trimethylheptadecan-15α-olyl-15-O-β-d-glucopyranosyl-1,5β-olide) demonstrated a significant reduction in the blood glucose as compared to standard metformin. Studies conducted by Hasan et al. [21] reviewed a list of medicinal plants and their compounds with proven antidiabetic activities in vivo and in vitro. The antidiabetic properties of these reported plants are often attributed to their different phytochemical constituents [22]. Interestingly, these phytochemicals are well distributed in many species, including the Helichrysum species used in folk medicine for the management of diabetes. However, there are inadequate studies reporting on Helichrysum species and their compounds used for the treatment of diabetes. Considering the traditional use of Helichrysum species in many parts of the world for the treatment of diabetes, the current study was undertaken to review the Helichrysum genus on species used in the management of diabetes and identify the bioactive constituents with reported antidiabetic activities. This review study is expected to identify the present knowledge gap and provide an important baseline for future studies.

2. Results and Discussions

2.1. An Overview of Ethnobotanical and Pharmacological Relevance of Helichrysum Genus

The Helichrysum genus encompasses typically aromatic herbs and shrubs with dense leaves that belong to the family of Asteraceae. The genus is widely distributed worldwide but is mostly found in Africa, with its highest diversity in South Africa, where about 500 known species occur. The plants belonging to this genus are well-known as everlasting flowers with leaves oblong to lanceolate. They have been in use for more than 3000 years for various folkloric purposes [23]. In traditional medicine, some Helichrysum plant parts are either drunk as teas or prepared as “burnt offering” smoke to appeal for blessings from the ancestors and are used to purify the home of the sick patients [24]. In addition, the plant from the Helichrysum genus has also been reported in traditional medicine for the treatment of several ailments, including stomach pain, gall bladder problems, jaundice, colds, wound healing, diabetes mellitus, skin infections, and asthma [25,26,27]. Nevertheless, with the emergence of scientific data on the use of Helichrysum species in the last few decades, some of the reported traditional claims have been scientifically supported. To mention a few, Tirillini et al. [28] reported the antioxidant activity of methanol extract of Helichrysum foetidum from east Africa. Additionally, research conducted by Matić et al. [29] revealed the antitumor potential of Helichrysum zivojinii extract. Another study conducted by Süzgeç-Selçuk and Birteksöz [30] reported the antimicrobial actions of flavonoids isolated from Helichrysum chasmolycicum. Ranaivoarisoa et al. [31] also reported the anti-plasmodial effect of Helichrysum gymnocephalum from Southern Africa. The anti-inflammatory activity of Helichrysum stoechas extracts from north Africa has also been reported [32] among others. It is imperative to note that several plants belonging to the Helichrysum genus have been more extensively researched for various bioactivities than their role as antidiabetic agents.

2.2. Antidiabetic Potentials of Helichrysum Species and Metabolites in Folk Medicine

Several Helichrysum species used for the treatment of diabetes have been identified in the literature (Table 1). Despite this, not all have been scientifically investigated for their antidiabetic activity (Table 2). In addition, only a few compounds obtained from these Helichrysum species have been shown to exhibit antidiabetic activity (Figure 2). Thus, in this section, a comprehensive description of plant species belonging to the genus Helichrysum used in the management of diabetes along with the compounds displaying antidiabetic activity will be elaborated.

2.2.1. Helichrysum arenarium

Description and Ethnobotanical Usage

Helichrysum arenarium (Figure 3) is a perennial herb that grows up to 50 cm in height with a robust and short rhizome [33]. The stem of the plant is generally branched at the upper part and carries alternate leaves of about 2 to 5 cm in length. H. arenarium is widely dispersed in Europe, Central Asia, and China [33]. The plant is well known in traditional medicine. The decoction from the aerial parts of H. arenarium is used for the treatment of diabetes [33]. The flowers are also reported to contain constituents and bitter substances used to promote gastric and pancreatic secretion. In addition, the infusions of the H. arenarium inflorescence are also used in the treatment of gallbladder disorders (rheumatism, cystitis, gout, arthritis) [34].

Toxicity

Kramberger et al. [36] documented the toxicity of H. arenarium. In the study, the authors revealed that the aqueous extract was only toxic at the highest concentration (5%, v/v) against lymphoma (U937) cells, while the same extract displayed toxicity even at 1% (v/v) concentration in both the human colorectal adenocarcinoma (Caco-2) and primary colon fibroblast (CCD112CoN) cell lines.

In Vitro Antidiabetic Study

Research conducted by Morikawa et al. [37] showed that the methanol extract of H. arenarium inhibited the dipeptidyl peptidase-IV (DPP4) activity with an IC50 value of 41.2 µg/mL.

In Vivo Antidiabetic Study

The in vivo antidiabetic studies conducted by Morikawa et al. [37] also revealed that the extract showed significant inhibition against the increase in blood glucose levels in sucrose-loaded mice at a concentration of 500 mg/kg.

Antidiabetic Activity of Isolated Compounds

Two compounds, chalconaringenin 2′-O-β-D-glucopyranoside (isosalipurposide, 1) and aureusidin 6-O-β-d-glucopyranoside (2), obtained from the methanol flower extract of H. arenarium have been reported to exhibit strong inhibition against DPP4 enzyme activity, with IC50 values of 23.1 and 24.3 μM, respectively [37]. The percentage composition of compounds 1 and 2 was reported to be 0.013% and 0.0025%, respectively [37].

2.2.2. Helichrysum aureum

Description and Ethnobotanical Usage

Helichrysum aureum (Figure 4) is a perennial plant with a woody rootstock and rosette of radical leaves. It has flowering stems of 0.1–0.6 m in height with small leaves. H. aureum is native to Swaziland, Zimbabwe, Angola, South Africa, and Mozambique. In South Africa, it is broadly dispersed in the Cape provinces, KwaZulu-Natal, and Free State. Traditionally, H. aureum is used by the people of Basotho for the treatment of diabetes [38].

Toxicity

The cytotoxicity study reported by Lourens et al. [40] revealed that the chloroform:methanol (1:1) extract of H. aureum displayed cytotoxic effects toward transformed human kidney epithelial (Graham) cells, breast adenocarcinoma (MCF-7), and glioblastoma (SF-268) cells at the tested concentration (0.1 mg/mL) with inhibition of 5%, 7%, and 35%, respectively.

In Vitro Antidiabetic Study

The literature surveys revealed no reported scientific validation of the in vitro antidiabetic activity of H. aureum.

In Vivo Antidiabetic Study

To date, there are no reported in vivo studies of any extracts from H. aureum.

Antidiabetic Activity of Isolated Compounds

Literature survey revealed no reports on the antidiabetic activity of compounds from H. aureum.

2.2.3. Helichrysum caespititium

Description and Ethnobotanical Usage

Helichrysum caespititium (Figure 5) is a perennial creeping plant of 10 to 20 cm in height. The leaves of the plant are linear, clutching at the base and hairy on both sides, while its flowers are white to yellow [41]. H. caespititium is broadly distributed in Lesotho, Zimbabwe, South Africa, and Swaziland [42]. In South Africa, the whole plant of H. caespititium is cooked and then used to alleviate diabetes mellitus [43]. Additionally, the plant is also used for the treatment of some medical conditions such as wounds, ulceration, skin infection diseases, nausea, tuberculosis, bronco-pneumonia, and sexually transmitted infections [27].

Toxicity

Research conducted by Mamabolo et al. [45] reported the toxicity of H. caespititium. The findings of the study showed that the whole plant extracts (hexane, dichloromethane, methanol, and aqueous extracts) of H. caespititium had low-to-high toxic effects in rat hepatoma (H411E) cell lines. In the study, the highest toxicity was reported for the dichloromethane whole plant extract of H. caespititium with a lethal concentration 50 (LC50) value of 82.86 μg/mL compared to the standard control, doxorubicin (LC50 = 10.80 μg/mL).

In Vitro Antidiabetic Study

It is imperative to note that the in vitro antidiabetic activity of H. caespititium has not been scientifically investigated.

In Vivo Antidiabetic Study

To date, there has been no report on the in vivo antidiabetic activity of H. caespititium in the literature.

Antidiabetic Activity of Isolated Compounds

Presently, information on the antidiabetic activity of isolated compound from H. caespititium is very scanty in the literature.

2.2.4. Helichrysum graveolens

Description and Ethnobotanical Usage

Helichrysum graveolens (Figure 6) is an herbaceous plant belonging to the Helichrysum genus, with grey-bushy foliage and thin everlasting flower-heads. The plant is native to Eastern Europe, Caucasus, Turkey, Iran, and South Africa [46]. Traditionally, the decoction from H. graveolens has been reported to be active in the treatment of diabetes mellitus in several regions of South Africa, Anatolia, and Turkey [46]. The capitulums of the plant are also reported to be consumed for the treatment of jaundice, diuretic, and wound healing in the rural districts of Anatolia [46].

Toxicity

Studies on the toxicity of H. graveolens revealed no toxicity activity displayed by the plant against the tested cells [48,49]. Kutluk et al. [48] investigated and reported that the whole plant aqueous and ethanol extracts were not toxic to Vero African green monkey kidney cell lines, even at the highest tested concentration of 64 µg/mL. Yazdi et al. [49] supported these results, whereby they reported no toxicity effects of the aerial parts aqueous extract of H. graveolens in C26 colon carcinoma cells up to 5.0 µg/mL concentration.

In Vitro Antidiabetic Study

Several reports have confirmed the antidiabetic activities of H. graveolens. Orhan et al. [50] revealed that the hydroethanolic extract from H. graveolens exhibited 55.7% inhibition at a concentration of 3000 µg/mL against alpha-amylase enzyme. In the same study, the authors also showed that the same extract demonstrated significant inhibition against the alpha-glucosidase enzyme with IC50 values of 0.7129 mg/mL.

In Vivo Antidiabetic Study

A study by Aslan et al. [46] showed that the aqueous and ethanol extracts of H. graveolens significantly reduced blood glucose levels in streptozotocin-induced diabetic rats at a 500 mg/kg dose concentration.

Antidiabetic Activity of Isolated Compounds

A literature search revealed no report of antidiabetic compounds from H. graveolens.

2.2.5. Helichrysum gymnocomum

Description and Ethnobotanical Usage

Helichrysum gymnocomum (Figure 7) is a straggling aromatic perennial herb with pleasantly scented flowers. The stems of the plant are often decumbent and rooting at the base while the leaves are very variable and pleasantly scented [24]. H. gymnocomum grows abundantly in the Eastern Cape and KwaZulu-Natal provinces of South Africa [51]. In addition, the plant is also native to Lesotho. Traditionally, the decoction of the fresh leaves of the plant is taken orally for the treatment of diabetes [52].

Toxicity

An extensive search of the literature at the time of compiling this review revealed no scientific report on the toxicity activity of H. gymnocomum.

In Vitro Antidiabetic Study

No reported in vitro studies were found in the literature.

In vivo antidiabetic study

No reported in vivo studies were found in the literature.

Antidiabetic activity of isolated compounds

Bioactive constituents in diabetes from H. gymnocomum are yet to be reported.

2.2.6. Helichrysum italicum

Description and Ethnobotanical Usage

Helichrysum italicum (Figure 8) is a small evergreen shrub that grows on dry, rocky, and sandy ground. It has small leaves with a revolute margin and woody stems at the base and is 60 cm or more in height. H. italicum is native to Mediterranean countries such as Turkey, Portugal, Italy, and Greece [54]. The infusion or decoction of the plant is traditionally used for the treatment of diabetes [55]. In addition, infusion and decoction are also used to treat dermatologic, digestive, and respiratory disorders.

Toxicity

Toxicity studies involving H. italicum have mainly been concerted in vitro [57]. Kramberger et al. [36] evaluated cell viability on lymphoma cell line (U937), adenocarcinoma cell line (Caco-2), and primary colon fibroblasts (CCD112CoN) after exposure to the aerial parts infusion of H. italicum. The study reported that the infusion was not toxic up to 5% v/v concentration in U937 cells, whereas for Caco-2 it was toxic at 1% v/v. A higher concentration (2% v/v) was toxic for CCD112CoN cells than for cancerous cell line Caco-2. Staver et al. [58] and Gismondi et al. [59] independently showed that H. italicum essential oil exhibited toxicity effects against HeLa human cervix adenocarcinoma (IC50 = 0.075 mg/mL) and MCF-7 human breast cancer (IC50 = 0.057 mg/mL) cells, as well as B16F10 murine melanoma, respectively, in a dose-dependent manner. Nostro et al. [60], in their research study assessing the genotoxicity of H. italicum, found that the diethyl ether extract of the plant exhibited no DNA damaging activity, even at the highest concentration (2000 g/disc).

In Vitro Antidiabetic Study

Research on the in vitro antidiabetic activity of H. italicum has been investigated [55,61,62]. The study conducted by Pereira et al. [55] revealed that the water-based preparation (infusion and decoction) from H. italicum flowers exhibited moderate inhibition of alpha-glucosidase activity compared to the control at 10 mg/mL. In the research study by de la Garza et al. [61], the methanol:water (1:1) extract of H. italicum was reported to exhibit significant inhibitory activity against both alpha-glucosidase and alpha-amylase enzymes, with IC50 values of 0.19 and 0.83 mg/mL, respectively. Aćimović et al. [62], in their research study, showed that H. italicum essential oil had strong inhibitory activity on alpha-glucosidase enzyme (62.02%) at the tested concentration (250 mg/mL).

In Vivo Antidiabetic Study

The in vivo study reported by de la Garza et al. [61] demonstrated that H. italicum methanol:water (1:1) extract reduced blood glucose levels, thereby improving postprandial glycemic control in rats. In a separate study [63], it was shown by the authors that the methanol:water (3:1) extract of H. italicum ameliorated hyperglycaemia in db/db mice. Another research study [64] revealed that the methanol:water (3:1) extract of H. italicum markedly reduced hyperinsulinemia and insulin resistance induced by high-fat sucrose (HFS) diet in insulin-resistant rats (at 2 g/kg concentration).

Antidiabetic Activity of Isolated Compounds

Presently, no studies have been reported on the antidiabetic activity of isolated compounds from H. italicum.

2.2.7. Helichrysum nudifolium

Description and Ethnobotanical Usage

Helichrysum nudifolium (Figure 9) is a fast-growing plant with a light-yellow inflorescence and shiny green leaves. The plant’s flowering stalks can reach 1.5 m in height. It is very easy to grow in the garden and is widely found in South Africa. In South Africa, it is one of the most important species culturally, medicinally, and historically [65]. Traditionally, the fresh leaves or roots of H. nudifolium are boiled and taken orally for the treatment of diabetes [66]. Additionally, the leaves and roots are also used as traditional medicine for wound dressing, internal sores, and chest complaints [65].

Toxicity

The study conducted by Lourens et al. [40] showed that the chloroform: methanol (1:1) extract of the plant displayed cytotoxicity activity with 73%, 83%, and 35% inhibitions, respectively, against transformed human kidney epithelial (Graham) cells, glioblastoma (SF-268) cells, and breast adenocarcinoma (MCF-7) at the tested concentration (0.1 mg/mL). Mokoka et al. [68], however, revealed that the whole plant dichloromethane:methanol (1:1) extract of H. nudifolium had low toxicity in rat myoblast L6 cells with a reported IC50 value of 47.7 µg/mL.

In Vitro Antidiabetic Study

The literature search revealed no reported in vitro antidiabetic activity of H. nudifolium.

In Vivo Antidiabetic Study

To date, there are no reported in vivo antidiabetic activities of H. nudifolium.

Antidiabetic activity of isolated compounds

Regrettably, there are no reports on the antidiabetic activity of the isolated compounds from H. nudifolium.

2.2.8. Helichrysum odoratissimum

Description and Ethnobotanical Usage

Helichrysum odoratissimum (Figure 10) is an aromatic, branched perennial plant with small grey leaves [69]. The leaves of the H. odoratissimum vary from linear-oblong, lingulate, to lanceolate. This plant has a yellow flowerhead borne in clusters at the tips of the twigs. H. odoratissimum is broadly found in South Africa, Mozambique, Zimbabwe, Lesotho, and Malawi [69]. In South Africa, it is found in the Eastern Cape across the mountains and coastal areas. In traditional medicine, the infusion from the whole plant is taken orally to treat diabetes [66]. In Lesotho, the whole plant part is mixed with other plants as herbal medicine to treat backache [69].

Toxicity

Studies on the toxicity of H. odoratissimum were documented by Lourens et al. [40] and Twilley et al. [71]. Lourens et al. [40] found the leaf and stem chloroform:methanol (1:1) extract of H. odoratissimum to be toxic against glioblastoma (SF-268) cells, transformed human kidney epithelial (Graham) cells, and breast adenocarcinoma (MCF-7) at 0.1 mg/mL, thereby displaying 48%, 17%, and 7.4% toxicity, respectively. While research conducted by Twilley et al. [71] revealed that the ethanol (100%) leaf and stem extract of H. odoratissimum exhibits toxicity against malignant melanoma (A 375), human embryonic kidney (HEK-293), human epidermoid carcinoma (A 431), and cervical epithelial carcinoma (HeLa) cell lines, with IC50 values at 55.5, 37.1, 33.1, and 15.5 µg/mL, respectively.

In Vitro Antidiabetic Study

Comprehensive search of the literature revealed no reports of in vitro antidiabetic activity of H. odoratissimum.

In Vivo Antidiabetic Study

The in vivo antidiabetic activity of the aqueous leaf extract of H. odoratissimum in alloxan-induced rats was demonstrated by Ngagi et al. [72]. The results indicated that the H. odoratissimum extract substantially lowered blood glucose levels in diabetic rats in a non-dose-dependent manner (between 50 to 150 mg/kg body weight).

Antidiabetic Activity of Isolated Compounds

To date, there are no reported studies involving the antidiabetic activity of the compounds from H. odoratissimum.

2.2.9. Helichrysum platicum

Description and Ethnobotanical Usage

Helichrysum plicatum (Figure 11) is a species belonging to the Helichrysum genus with simple and broad leaves. It is an herbaceous perennial plant that grows up to 0.24 m in height. H. platicum is widely found in Balkan, Iran, and Anatolian Peninsulas [73]. The infusion prepared from the plant is used to suppress diabetes symptoms [74].

Toxicity

Eroglu et al. [76] reported that the methanol (100%) flower extract of H. platicum exhibits toxicity properties in human lymphocytes at 0.5 mg/mL concentration. A separate study conducted by Bigović et al. [77] documented moderate toxicity of the ethanol (100%) and ethyl acetate: ethanol (100:0) flower extracts of the plant against human cervix adenocarcinoma cells (HeLa), prostate cancer (PC3) cells, and myelogenous leukemia (K562) cells, with IC50 values at 42.1 ± 0.05, 39.2 ± 1.1, and 25.9 ± 1.5 µg/mL, respectively.

In Vitro Antidiabetic Study

To the best of our knowledge, there are no reported of in vitro antidiabetic studies of H. plicatum.

In Vivo Antidiabetic Study

A research study indicated by Aslan et al. [78] revealed the in vivo antidiabetic activity of H. plicatum aqueous and ethanol extracts in normal and streptozotocin-induced diabetic rats. In the study, the results showed that the aqueous and ethanol extracts demonstrated significant antihyperglycemic activity at a concentration of 500 mg/kg body weight as compared with tolbutamide used as a positive control.

Antidiabetic Activity of Isolated Compounds

A comprehensive literature search showed that compounds such as isosalipurposide (102 mg), helichrysin A (87 mg), helichrysin B (220 mg), apigenin (300 mg), astragalin (28 mg), β-sitosterol (35 mg), β-sitosterol-3-O-β-d-glucopyranoside (25 mg), and nonacosanoic acid (15 mg), isolated from H. platicum methanol extract have been reported to exhibit alpha-glucosidase activity [79].

2.2.10. Helichrysum petiolare

Description and Ethnobotanical Usage

Helichrysum petiolare (Figure 12) is a vigorous shrub with silver-gray hair covering the aromatic round-shaped leaf [80]. It is one of the well-known and most used members of the Helichrysum genus. The plant grows to about 0.5 to 1 m in height with its flower whitish-cream in color. H. petiolare is found in the drier inland parts of South African provinces, such as the Eastern Cape and KwaZulu-Natal [81]. In South African traditional medicine, the infusion of the whole plant is taken orally to treat diabetes [66]. In addition, the decoction of the leaves of H. petiolare is used to improve skin texture and for wound healing [82].

Toxicity

An extensive search of the literature revealed at least three documented studies investigating the toxicity of H. petiolare [40,84,85]. Lourens et al. [40] reported that the chloroform:methanol (1:1) extract of H. petiolare had toxic effects on glioblastoma (SF-268), transformed human kidney epithelial (Graham), and breast adenocarcinoma (MCF-7) cells at 0.1 mg/mL, showing 76%, 59%, and 33% activity, respectively. The work of Aladejana et al. [84] revealed that the whole plant ethanol extract of H. petiolare demonstrated significant toxicity in L6 myocytes cells and HepG2 (C3A) hepatocytes at 100 μg/mL concentration. Sagbo and Otang-Mbeng [85] in their toxicity assessment of the methanol extract of H petiolare also reported that the extract was toxic against B16F10 mouse melanoma cells and MeWo human melanoma cells in a dose-dependent manner. The same group [85] also reported the genotoxicity of the plant extract (methanol) against the Vero cell line at the highest three concentrations tested (50, 100, and 200 µg/mL).

In Vitro Antidiabetic Study

The in vitro antidiabetic potential of H. petiolare using human hepatoma (HepG2/C3A) and rat skeletal (L6) myoblast cell lines has been shown [84]. The results of the study indicated that the whole plant boiled and cold aqueous extracts of H. petiolare significantly increased glucose uptake in L6 and HepG2/C3A cell lines at 25 µg/mL and 50 µg/mL, respectively. In the same study, it was also indicated that the extracts inhibited alpha-amylase and alpha-glucosidase activities in a dose-dependent manner as compared to the respective positive controls. In another study [86], the aqueous acetone extract of H. petiolare was shown to display an increased glucose uptake in HepG2 cells in a concentration-dependent manner and had moderate inhibitory effects against alpha-amylase and alpha-glucosidase activity compared to the acarbose, the positive control used in the study.

In Vivo Antidiabetic Study

To the best of our knowledge, there are no antidiabetic studies reported in vivo.

Antidiabetic Activity of Isolated Compounds

The compounds of H. petiolare displaying antidiabetic activity are yet to be reported.
Table
Table 1. Helichrysum species used in the management of diabates mellitus.
Table 1. Helichrysum species used in the management of diabates mellitus.
S/NHelichrysum SpeciesPlant Part UsedMode of PreparationCountry Used for DiabetesReference
1Helichrysum arenarium (L.) MoenchAerial partThe aerial parts are used to make a decoction which is then taken orallyTurkey[87]
2Helichrysum armenium DC. subsp. ArmeniumAerial partsThe decoction from the aerial parts is then taken orallyTurkey[88]
3Helichrysum aureum (Houtt.) Merr.LeavesThe crude (aqueous extract) is taken orallySouth Africa, Mozambique, Zimbabwe, Lesotho, and Swaziland[38]
4Helichrysum caespititium (DC.) Harv.Whole plantThe whole plant is cooked and then taken orallySouth Africa[43,89]
5Helichrysum chionophilum Boiss. & Balansa UnspecifiedUnspecifiedTurkey[90]
6Helichrysum crispum (L.) D. DonUnspecifiedThe infusion is taken orallySouth Africa[91]
7Helichrysum cymosum (L.) D. Don subsp. cymosumUnspecifiedUnspecifiedSouth Africa[92]
8Helicrysum devium J.Y. JohnsonUnspecifiedUnspecifiedPortugal[93]
9Helichrysum foetidum (L.) MoenchUnspecifiedUnspecifiedSouth Africa[9]
10Helichrysum graveolens (Bieb.) SweetCapitulumsThe capitlums decoction is taken orallyAnatolia, Turkey, and South Africa[46]
11Helichrysum gymnocomum DC var. acuminatum DC.DC.LeavesThe leaves are used to make a decoction and then taken orally.South Africa[52]
12Helichrysum italicum (Roth) G. DonUnspecifiedThe infusion is taken orallyTurkey, Portugal, Italy, and Greece[18,55]
13Helichrysum melaleucum Rchb. Ex HollUnspecifiedUnspecifiedPortugal[93]
14Helichrysum monizii Lowe.UnspecifiedUnspecifiedPortugal[93]
15Helichrysum nudifolium (L.) Less. Leaves, rootsThe decoction prepared from the leaves or roots is taken orally.South Africa[66]
16Helichrysum obconicum DC.UnspecifiedUnspecifiedPortugal[93]
17Helichrysum odoratissimum (L.) SweetWhole plantThe whole plant parts are used to make a decoction which is then taken orallySouth Africa[72]
18Helichrysum pallasii (Sprengel) LedebLeaf, FlowerThe leaf or flower is used to make Infusion which is then taken orallyTurkey[88]
19Helichrysum plicatum DC.FlowerThe flower is used to make infusion where is then taken orallySolhan, Anatolia, and Turkey[74]
20Helichrysum petiolare Hilliard & B.L. BurttWhole plantThe infusion prepared from the fresh plant is taken orally.South Africa[66]
21Helichrysum sanguineum (L.) Kostel.UnspecifiedUnspecifiedPalestine[94]
22Helichrysum stoechas (L.) MoenchUnspecifiedUnspecifiedSpain[95]
Table
Table 2. Reported antidiabetic activities of Helichrysum species.
Table 2. Reported antidiabetic activities of Helichrysum species.
S/NHelichrysum SpeciesPlant Part UsedExtractAntidiabetic Isolated CompoundsToxicityAntidiabetic Mechanism of ActionModelReference
1H. arenariumFlowersMethanolIsosalipurposide (1), aureusidin 6-O-β-d-glucopyranoside (2)Toxic to Caco-2 and CCD112CoN at 1% v/v concentrationInhibit Dipeptidyl peptidase-4 (DPP-4) activity and inhibitory effect against the increase in blood glucose levels in sucrose-loaded mice at 500 mg/kg concentrationIn vitro and in vivo[36,37]
2H. aureum***Displayed cytotoxic effects toward Graham, MCF-7, and SF-268 cells at 0.1 mg/mL**[40]
3H. caespititium***The dichloromethane extract has moderate toxicity toward H411E cell at 82.86 µg/mL concentration**[45]
4H. chionophilumFlowers and stemEthanol, methanol, and ethyl acetate**Inhibit alpha-glucosidase (between 3.77 to 25.42 mmol) and alpha-amylase (between 149.16 to 193.36 mmol) activitiesIn vitro[90]
5H. cymosum (L.) D. Don subsp. cymosumAerial partsMethanolAllopatuletin (3), dihydrobaicalein (4), helichrysetin (5)Displayed cytotoxicity towards transformed human kidney epithelial cells at 17.47 µg/mLInhibit alpha-glucosidase activity between 14 to 44 µM concentrationsIn vitro[92,96]
6H. deviumLeaves, flowersMethanol*Toxic to Brin shrimp larvae between 2.36 to 4.85 µg/mL Inhibit alpha-glucosidase (between 1.44 to 2.13 mg/mL) and alpha-amylase (between 1.85 to 2.39 mg/mL) activitiesIn vitro[93,97]
9H. foetidumLeaves, flowersMethanolHelichrysetin (5)Reported toxicity to Ha-CaT keratinocytes cells between 20 to 100 µg/mLInhibit alpha-glucosidase activity between 19.4 to 27.3 µg/mLIn vitro[9]
10H. graveolensCapitulumsEthanol, hydro-ethanolic and water*Not cytotoxic in Vero African green monkey kidney (up to 64 µg/mL) and C26 cells (up to 5.0 µg/mL)Reduction of blood glucose levels in streptozotocin-induced diabetic rat (at 500 mg/kg), inhibition against alpha-glucosidase (at 0.7129 mg/mL), and alpha-amylase (at 3 mg/mL) activitiesIn vitro and in vivo[46,48,49,50]
11H. italicumFlowersMethanol-water*Toxic to U937 cell line (at 5% v/v concentration), Caco-2 cell line (at 1% v/v concentration), CCD112CoN cell line (at 2% v/v concentration), HeLa cell line (at 0.075 mg/mL), MCF-7 cell line (0.057 mg/mL), and B16F10 cell lineThe inhibition against alpha-glucosidase (IC50 = 0.19 mg/mL) and alpha-amylase (IC50 = 0.83 mg/mL) activities and reduction of blood glucose levels in rats (at 2g/kg dose concentration)In vitro and in vivo[58,59,61]
12H. melaleucumLeaves, flowersMethanol*Toxic to Brin shrimp larvae between 0.18 to 7.64 µg/mL concentrationsInhibit alpha-glucosidase (between 0.99 to 0.125 mg/mL) and alpha-amylase (between 1.71 to 2.15 mg/mL) activitiesIn vitro[92,97]
13H. moniziiAerial partsMethanol**Inhibit alpha-glucosidase (at 2.76 mg/mL) and alpha-amylase (4.29 mg/mL) activitiesIn vitro[93]
14H. nudifolium***Exhibits cytotoxicity effects to Graham (at 0.1 mg/mL), SF-268 (at 0.1 mg/mL), MCF-7 (at 0.1 mg/mL), and rat myoblast L6 cells (IC50 = 47.7 µg/mL)**[40,68]
15H. obconicumLeavesMethanol*Toxic to Brin shrimp larvae between 0.57 to 15.0 µg/mL concentrationsInhibit alpha-glucosidase (at 1.35 mg/mL) and alpha-amylase (at 2.48 mg/mL) activitiesIn vitro[93,97]
16H. odoratissimumLeavesAqueous*Shows toxicity to SF-268 (at 0.1 mg/mL), Graham (at 0.1 mg/mL), MCF-7 (at 0.1 mg/mL), A375 (IC50 = 55.5 µg/mL), HEK-293 (IC50 = 37.1 µg/mL), A431 (IC50 = 33.1 µg/mL), and HeLa (IC50 = 15.5 µg/mL) cellsReduction of blood glucose level in the diabetes rat between 50 to 150 mg/kg dose concentrationIn vivo[40,71,72]
17H. plicatumCapitulumsAqueous and ethanolIsosalipurposide (1), helichrysin A (6), helichrysin B (7), apigenin (8), astragalin (9), β-sitosterol (10), β-sitosterol-3-glucoside (11), and nonacosanoic acid (12)Exhibits toxicity effects against HeLa (IC50 = 42.1 µg/mL), PC3 (IC50 = 39.2 µg/mL), K562 (IC50 = 25.1 µg/mL), and human lymphocytes (at 0.5 mg/mL)Reduction of blood glucose levels in streptozotocin-induced diabetic rat at 500 mg/mL dose concentrationIn vivo[76,78,79]
18H. petiolareWhole plantAqueous*Toxic to SF-268 (at 0.1 mg/mL), Graham (0.1 mg/mL), MCF-7 (at 0.1 mg/mL), HepG2 (C3A), L6 (at 100 µg/mL), B16F10 (between 25 to 100 µg/mL), MeWo (between 12.5 to 100 µg/mL), and Vero cells (between 50 to 200 µg/mL)Enhance glucose uptake in L6 (at 25 µg/mL) and C3A (at 50 µg/mL) cell lineIn vitro[40,84,85]
19H. sanguineumAerial partsAqueous*Reported to be toxic at high concentrations on human lymphocyte cells at 0.5 mg/mL concentrationInhibit alpha-amylase activity with an IC50 = 28.1 µg/mLIn vitro[94,98]
20H. stoechasAerial partsMethanol *Moderate toxicity was reported at the highest concentration (1 mg/mL) in HeLa cellsInhibit alpha-amylase (between 0.46 to 0.63 mmol), alpha-glucosidase (IC50 = 481.0 µg/mL), and DPP-4 activity (IC50 = 81.7 µg/mL)In vitro[95,99]
* = Not available.

3. Material and Methods

A comprehensive literature survey was carefully conducted from August 2021 to February 2022. A report about the Helichrysum genus used traditionally in the management of diabetes was retrieved from various scientific databases such as Science Direct, Medline, Scopus, Web of Science, PubMed, Google Scholar, and Medline. In addition, ethnobotanical books, theses, and dissertations were also retrieved from various university libraries. The keywords and terms used during the search to obtain relevant articles or research papers were “Helichrysum species”, “diabetes”, “traditional medicine”, and “ethnopharmacology”.

4. Conclusions and Recommendations

The present study reviews the Helichrysum genus and its compounds’ activities in the management of diabetes mellitus. Out of the twenty-two Helichrysum species reported for the management of diabetes, only fifteen species have been scientifically evaluated, and many of these reported species exhibited their antidiabetic through inhibition of carbohydrate hydrolyzing enzymes (alpha-amylase and alpha-glucosidase) and reduction of blood glucose levels in streptozotocin-induced diabetic rats. The antidiabetic effects of these plants are attributed to several antidiabetic compounds, and only a few bioactive compounds have been identified in some species. However, it is worth noting that effort should be made to isolate more antidiabetic compounds from these species. In addition, an effort also needs to be devoted to the mechanism of antidiabetic action (in vitro and in vivo studies) of many previously explored and unexplored Helichrysum species.

Author Contributions

Conceptualization, W.T.M. and A.A.H.; writing—original draft, A.O.A., I.J.S. and M.M.; editing, I.J.S., M.M., W.T.M. and A.A.H.; supervision, W.T.M. and A.A.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors acknowledge the support of the Cape Peninsula University of Technology and the University of the Western Cape towards the successful completion of this review article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Internal Diabets Federation (IDF). IDF Diabates Atlas. 2019. Available online: https://diabetesatlas.org/atlas/ninth-edition/ (accessed on 23 January 2022).
  2. Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martín, C. Pathophysiology of Type 2 diabetes Mellitus. Int. J. Mol. Sci. 2020, 21, 6275. [Google Scholar] [CrossRef] [PubMed]
  3. Medscape. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Available online: https://www.medscape.com/viewarticle/412642_2 (accessed on 24 January 2022).
  4. Mahmood, N. A review of α-amylase inhibitors on weight loss and glycemic control in pathological state such as obesity and diabetes. Comp. Clin. Path. 2016, 25, 1253–1264. [Google Scholar] [CrossRef]
  5. Pieme, C.A.; Tatangmo, J.A.; Simo, G.; Cabral, P.; Nya, B.; Jocelyne, V.; Moor, A.; Moukette, B.M.; Nzufo, F.T.; Legrand, B.; et al. Relationship between hyperglycemia, antioxidant capacity and some enzymatic and non-enzymatic antioxidants in African patients with type 2 diabetes. BMC Res. Notes 2017, 10, 141. [Google Scholar] [CrossRef] [Green Version]
  6. Perkins, R.M.; Yuan, C.M.; Welch, P. Dipsogenic diabetes insipidus: Report of a novel treatment strategy and literature review. Clin. Exp. Nephrol. 2006, 10, 63–66. [Google Scholar] [CrossRef]
  7. Bedekar, A.; Shah, K.; Koffas, M. Natural products for type II diabetes treatment. Adv. Appl. Microbiol. 2010, 71, 21–73. [Google Scholar] [PubMed]
  8. Osadebe, P.O.; Odoh, E.U.; Uzor, P.F. Natural products as a potential sources of antidiabetic drugs. Br. J. Pharm. Res. 2014, 4, 2075–2095. [Google Scholar] [CrossRef]
  9. Omolaja, A.A.; Pearce, B.; Omoruyi, S.I.; Badmus, J.A.; Ismail, E.; Marnewick, J.; Botha, S.; Benjeddou, M.; Ekpo, O.E.; Hussein, A.A. The potential of chalcone-capped gold nanoparticles for the management of diabetes mellitus. Surf. Interfaces 2021, 25, 101251. [Google Scholar] [CrossRef]
  10. Hung, H.; Qian, K.; Morris-natschke, S.L.; Hsu, C.; Lee, K. Recent discovery of plant-derived anti-diabetic natural products. Nat. Prod. Rep. 2012, 29, 580–606. [Google Scholar] [CrossRef]
  11. Rahmatullah, M.; Azam, N.K.; Khatun, Z.; Seraj, S.; Islam, F.; Rahman, A.; Jahan, S.; Aziz, S. Medicinal plants used for treatment of diabetes by the Marakh Sect of the Garo Tribe living in Mymensingh district, Bangladesh. Afr. J. Tradit. Complement. Altern. Med. 2012, 9, 380–385. [Google Scholar] [CrossRef] [Green Version]
  12. Ocvirk, S.; Kistler, M.; Khan, S.; Talukder, S.H.; Hauner, H. Traditional medicinal plants used for the treatment of diabetes in rural and urban areas of Dhaka, Bangladesh—An ethnobotanical survey. J. Ethnobiol. Ethnomed. 2013, 9, 43. [Google Scholar] [CrossRef] [Green Version]
  13. Odeyemi, S.; Greame, B. Medicinal plants used for the traditional management of diabetes in the Eastern cape, South Africa:pharmacology and toxicology. Molecules 2018, 23, 2759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Kooti, W.; Farokhipour, M.; Asadzadeh, Z.; Ashtary-Larky, D.; Asadi-Samani, M. The role of medicinal plants in the treatment of diabetes: A systematic review. Electron. Physician 2016, 8, 1832–1842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Kasole, R.; Martin, H.D.; Kimiywe, D. Traditional medicine and Its role in the management of Diabetes mellitus: “patients’ and herbalists’ perspectives”. Evid.-Based Complement. Altern. Med. 2019, 2019, 2835691. [Google Scholar] [CrossRef] [PubMed]
  16. Brusotti, G.; Cesari, I.; Dentamaro, A.; Caccialanza, G.; Massolini, G. Isolation and characterization of bioactive compounds from plant resources: The role of analysis in the ethnopharmacological approach. J. Pharm. Biomed. Anal. 2014, 87, 218–228. [Google Scholar] [CrossRef] [PubMed]
  17. Chinsembu, K.C. Diabetes mellitus and nature’s pharmacy of putative antidiabetic plants. J. Herb. Med. 2019, 15, 100230. [Google Scholar] [CrossRef]
  18. Salehi, B.; Ata, A.; Anil Kumar, N.V.; Sharopov, F.; Ramírez-Alarcón, K.; Ruiz-Ortega, A.; Ayatollahi, S.A.; Fokou, P.V.T.; Kobarfard, F.; Zakaria, Z.A. Antidiabetic potential of medicinal plants and their active components. Biomolecules 2019, 9, 551. [Google Scholar] [CrossRef] [Green Version]
  19. Duarte, A.M.; Guarino, M.P.; Barroso, S.; Gil, M.M. Phytopharmacological strategies in the management of type 2 diabetes mellitus. Foods 2020, 9, 271. [Google Scholar] [CrossRef] [Green Version]
  20. IfedibaluChukwu, E.I.M.; Aparoop, D.; Kamaruz, Z. Antidiabetic, anthelmintic and antioxidation properties of novel and new phyto compounds isolated from the methanolic stem-bark of Vernonia amygdalina Delile (Asteraceae). Sci. Afr. 2020, 10, e00578. [Google Scholar]
  21. Hasan, M.; Uddin, Q.; Zaiton, S.; Soad, M.; Sarwar, T. Animal models and natural products to investigate in vivo and in vitro antidiabetic activity. Biomed. Pharmacother. 2018, 101, 833–841. [Google Scholar] [CrossRef]
  22. Ardalani, H.; Amiri, F.H.; Hadipanah, A.; Kongstad, K.T. Potential antidiabetic phytochemicals in plant roots: A review of in vivo studies. J. Diabetes Metab. Disord. 2021, 20, 1837–1854. [Google Scholar] [CrossRef]
  23. Akinyede, K.A.; Cupido, C.N.; Hughes, G.D.; Oguntibeju, O.O. Medicinal properties and In vitro biological activities of selected Helichrysum species from South Africa: A review. Plants 2021, 10, 1566. [Google Scholar] [CrossRef] [PubMed]
  24. Pooley, E. Mountain Flowers: A Field Guide to the Flora of the Drakensberg and Lesotho; Flora Publications Trust: Durban, South Africa, 2003. [Google Scholar]
  25. Antunes Viegas, D.; Palmeira-de-Oliveira, A.; Martinez-de-Oliveira, J.; Palmeira-de-Oliveira, R. Helichrysum italicum: From traditional use to scientific data. J. Ethnopharmacol. 2014, 151, 54–65. [Google Scholar] [CrossRef] [PubMed]
  26. Rigano, D.; Formisano, C.; Pagano, E.; Senatore, F.; Piacente, S.; Masullo, M.; Capasso, R.; Izzo, A.A.; Borrelli, F. A new acetophenone derivative from flowers of Helichrysum italicum (Roth) Don ssp. italicum. Fitoterapia 2014, 99, 198–203. [Google Scholar] [CrossRef] [PubMed]
  27. Maroyi, A. Helichrysum caespititium (DC.) Harv.: Review of its medicinal uses, phytochemistry and biological activities. J. Appl. Pharm. Sci. 2019, 9, 111–118. [Google Scholar]
  28. Tirillini, B.; Menghini, L.; Leporini, L.; Scanu, N.; Marino, S.; Pintore, G. Antioxidant activity of methanol extract of Helichrysum foetidum Moench. Nat. Prod. Res. 2013, 27, 1484–1487. [Google Scholar] [CrossRef]
  29. Matić, I.Z.; Aljančić, I.; Žižak, Ž.; Vajs, V.; Jadranin, M.; Milosavljević, S.; Juranić, Z.D. In vitro antitumor actions of extracts from endemic plant Helichrysum zivojinii. BMC Complement. Altern. Med. 2013, 13, 36. [Google Scholar] [CrossRef] [Green Version]
  30. Süzgeç-Selçuk, S.; Birteksöz, A.S. Flavonoids of Helichrysum chasmolycicum and its antioxidant and antimicrobial activities. S. Afr. J. Bot. 2011, 77, 170–174. [Google Scholar] [CrossRef] [Green Version]
  31. Ranaivoarisoa, R.H.; Ralambonirina, S.T.R.; Randriamialinor, F.; Randrianasolo, R.; Ratsimbason, M.; Ranarivelo, L.R. Antiplasmodial Activity of the Extracts and Flavonoids Isolated from Helichrysum gymnocephalum Humbert (Asteraceae) from Madagascar. ACS Symp. Ser. 2020, 1361, 171–178. [Google Scholar]
  32. Kherbache, A.; Senator, A.; Laouicha, S.; Al-Zoubi, R.M.; Bouriche, H. Phytochemical analysis, antioxidant and anti-inflammatory activities of Helichrysum stoechas (L.) Moench extracts. Biocatal. Agric. Biotechnol. 2020, 29, 101826. [Google Scholar] [CrossRef]
  33. Pljevljakušić, D.; Bigović, D.; Janković, T.; Jelačić, S.; Šavikin, K. Sandy everlasting (Helichrysum arenarium (L.) Moench): Botanical, chemical and biological properties. Front. Plant Sci 2018, 1123. [Google Scholar] [CrossRef] [Green Version]
  34. Shikov, A.N.; Pozharitskaya, O.N.; Makarov, V.G.; Wagner, H.; Verpoorte, R.; Heinrich, M. Medicinal plants of the Russian Pharmacopoeia; their history and applications. J. Ethnopharmacol. 2014, 154, 481–536. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. POWO. Plants of the World Online. Facilitated by the Royal Botanic Gardens, Kew. 2022. Available online: https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:212418-1 (accessed on 11 May 2022).
  36. Kramberger, K.; Pražnikar, Z.J.; Baruca Arbeiter, A.; Petelin, A.; Bandelj, D.; Kenig, S. A comparative study of the antioxidative effects of Helichrysum italicum and Helichrysum arenarium infusions. Antioxidants 2021, 10, 380. [Google Scholar] [CrossRef]
  37. Morikawa, T.; Ninomiya, K.; Akaki, J.; Kakihara, N.; Kuramoto, H.; Matsumoto, Y.; Hayakawa, T.; Muraoka, O.; Wang, L.-B.; Wu, L.-J.; et al. Dipeptidyl peptidase-IV inhibitory activity of dimeric dihydrochalcone glycosides from flowers of Helichrysum arenarium. J. Nat. Med. 2015, 69, 494–506. [Google Scholar] [CrossRef] [Green Version]
  38. Balogun, F.O.; Tshabalala, N.T.; Ashafa, A.O.T. Antidiabetic medicinal plants used by the Basotho Tribe of Eastern Free State: A Review. J. Diabetes Res. 2016, 2016, 4602820. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. SANBI (South African National Biodiversity Institute). Red List of South African Plants. Available online: http://redlist.sanbi.org/species.php?species=3240-4002 (accessed on 28 February 2022).
  40. Lourens, A.C.U.; Van Vuuren, S.F.; Viljoen, A.M.; Davids, H.; Van Heerden, F.R. Antimicrobial activity and in vitro cytotoxicity of selected South African Helichrysum species. S. Afr. J. Bot. 2011, 77, 229–235. [Google Scholar] [CrossRef] [Green Version]
  41. Meyer, J.J.M.; Lall, N.; Mathekga, A.D.M.; Jäger, A.K. In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by Helichrysum caespititium. S. Afr. J. Bot. 2002, 68, 90–93. [Google Scholar] [CrossRef]
  42. Arnold, T.H.; Prentice, C.A.; Hawker, L.C.; Snyman, E.E.; Tomalin, M.; Crouch, N.R.; Pottas-Bircher, C. Medicinal and Magical Plants of Southern Africa: An Annotated Checklist; National Botanical Institute: Pretoria, South Africa, 2002. [Google Scholar]
  43. Makhafola, M.; Middleton, L.; Olivier, M.; Olaokun, O. Cytotoxic and antibacterial activity of selected medicinal. Asian J. Chem. 2019, 31, 2623–2627. [Google Scholar] [CrossRef]
  44. Hyde, M.A.; Wursten, B.T.; Ballings, P.; Coates Palgrave, M. Flora of Zimbabwe: Species Information: Individual Images: Helichrysum caespititium. Available online: https://www.zimbabweflora.co.zw/speciesdata/image-display.php?species_id=159510&image_id=5 (accessed on 28 February 2022).
  45. Mamabolo, M.P.; Muganza, F.M.; Olivier, M.T.; Olaokun, O.O.; Nemutavhanani, L.D. Evaluation of antigonorrhea activity and cytotoxicity of Helichrysum caespititium (DC) Harv. whole plant extracts. Biol. Med. 2018, 10, 1000422. [Google Scholar] [CrossRef]
  46. Aslan, M.; Orhan, D.D.; Orhan, N.; Sezik, E.; Yeşilada, E. A study of antidiabetic and antioxidant effects of Helichrysum graveolens Capitulums in Streptozotocin-Induced Diabetic Rats. J. Med. Food. 2007, 10, 396–400. [Google Scholar] [CrossRef]
  47. POWO. Plants of the World Online. Facilitated by the Royal Botanic Gardens, Kew. Helichrysum graveolens. 2022. Available online: https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:212825-1#bibliography (accessed on 28 February 2022).
  48. Kutluk, I.; Aslan, M.; Orhan, I.E.; Özçelik, B. Antibacterial, antifungal and antiviral bioactivities of selected Helichrysum species. S. Afr. J. Bot. 2018, 119, 252–257. [Google Scholar] [CrossRef]
  49. Yazdi, T.; Ehsan, M.; Amiri, M.S.; Akbari, S.; Sharifalhoseini, M.; Nourbakhsh, F.; Mashreghi, M.; Abbasi, M.R.; Modarres, M.; Es-haghi, A. Green synthesis of silver nanoparticles using Helichrysum graveolens for biomedical applications and wastewater treatment. BioNanoScience 2020, 10, 1121–1127. [Google Scholar] [CrossRef]
  50. Orhan, N.; Hoçbaç, S.; Orhan, D.D.; Asian, M.; Ergun, F. Enzyme inhibitory and radical scavenging effects of some antidiabetic plants of Turkey. Iran. J. Basic Med. Sci. 2014, 17, 426–432. [Google Scholar] [PubMed]
  51. Drewes, S.F.; van Vuuren, S.E. Antimicrobial acylphloroglucinols and dibenzyloxy flavonoids from flowers of Helichrysum gymnocomum. Phytochemistry 2008, 69, 1745–1749. [Google Scholar] [CrossRef]
  52. Oyedemi, S.O.; Bradley, G.; Afolayan, A.J. Ethnobotanical survey of medicinal plants used for the management of diabetes mellitus in the Nkonkobe municipality of South Africa. J. Med. Plant Res. 2009, 3, 1040–1044. [Google Scholar]
  53. FOSTER (The Friends of the St Francis Nature Areas). Available online: https://foster.org.za/plant-gallery-2/ (accessed on 28 February 2022).
  54. Roussis, V.; Tsoukatou, M.; Petrakis, P.V.; Ioanna, C.; Skoula, M.; Harborne, J.B. Volatile constituents of four Helichrysum species growing in Greece. Biochem. Syst. Ecol. 2000, 28, 163–175. [Google Scholar] [CrossRef]
  55. Pereira, C.G.; Barreira, L.; Bijttebier, S.; Pieters, L.; Neves, V.; Rodrigues, M.J.; Rivas, R.; Varela, J.; Custódio, L. Chemical profiling of infusions and decoctions of Helichrysum italicum subsp. picardii by UHPLC-PDA-MS and in vitro biological activities comparatively with green tea (Camellia sinensis) and rooibos tisane (Aspalathus linearis). J. Pharm. Biomed. Anal. 2017, 145, 593–603. [Google Scholar] [CrossRef] [PubMed]
  56. American Botanical Council. Available online: https://www.herbalgram.org/resources/herbalgram/issues/105/table-of-contents/hg105-feat-helichrysum/ (accessed on 28 February 2022).
  57. Kramberger, K.; Kenig, S.; Pražnikar, Z.J.; Glavač, N.K.; Barlič-Maganja, D. A Review and Evaluation of the Data Supporting Internal Use of Helichrysum italicum. Plants 2021, 10, 1738. [Google Scholar] [CrossRef]
  58. Staver, M.M.; Gobin, I.; Ratkaj, I.; Petrovic, M.; Vulinovic, A.; Dinarina-Sablic, M.; Broznic, D. In vitro antiproliferative and antimicrobial activity of the essential oil from the flowers and leaves of Helichrysum italicum (Roth) G. Don growing in central Dalmatia (Croatia). J. Essent. Oil Bear. Plants 2018, 21, 77–91. [Google Scholar] [CrossRef]
  59. Gismondi, A.; Di Marco, G.; Canini, A. Helichrysum italicum (Roth) G. Don essential oil: Composition and potential antineoplastic effect. S. Afr. J. Bot. 2020, 133, 222–226. [Google Scholar] [CrossRef]
  60. Nostro, A.; Cannatelli, M.A.; Marino, A.; Picerno, I.; Pizzimenti, F.C.; Scoglio, M.E.; Spataro, P. Evaluation of antiherpesvirus-1 and genotoxic activities of Helichrysum italicum extract. New Microbiol. 2003, 26, 125–128. [Google Scholar]
  61. de la Garza, A.L.; Etxeberria, U.; Lostao, M.P.; San Román, B.; Barrenetxe, J.; Martínez, J.A.; Milagro, F.I. Helichrysum and grapefruit extracts inhibit carbohydrate digestion and absorption, improving postprandial glucose levels and hyperinsulinemia in Rats. J. Agric. Food Chem. 2013, 61, 12012–12019. [Google Scholar] [CrossRef]
  62. Aćimović, M.; Ljujić, J.; Vulić, J.; Zheljazkov, V.D.; Pezo, L.; Varga, A.; Tumbas Šaponjac, V. Helichrysum italicum (Roth) G. Don Essential Oil from Serbia: Chemical Composition, Classification and Biological Activity—May It Be a Suitable New Crop for Serbia? Agronomy 2021, 11, 1282. [Google Scholar] [CrossRef]
  63. de la Garza, A.L.; Etxeberria, U.; Palacios-Ortega, S.; Haslberger, A.G.; Aumueller, E.; Milagro, F.I.; Martínez, J.A. Modulation of hyperglycemia and TNFα-mediated inflammation by Helichrysum and grapefruit extracts in diabetic db/db mice. Food Funct. 2014, 5, 2120–2128. [Google Scholar] [CrossRef] [PubMed]
  64. de la Garza, A.L.; Etxeberria, U.; Haslberger, A.; Aumueller, E.; Martínez, J.A.; Milagro, F.I. Helichrysum and grapefruit extracts boost weight loss in overweight rats reducing inflammation. J. Med. Food 2015, 18, 890–898. [Google Scholar] [CrossRef]
  65. Van Wyk, B.E.; Gorelik, B. The history and ethnobotany of Cape herbal teas. S. Afr. J. Bot. 2017, 110, 18–38. [Google Scholar] [CrossRef]
  66. Erasto, P.; Adebola, P.; Grierson, D.; Afolayan, A.J. An ethnobotanical study of plants used for the treatment of diabetes in the Eastern Cape Province, South Africa. Afr. J. Biotechnol. 2005, 4, 1458–1460. [Google Scholar]
  67. Hyde, M.A.; Wursten, B.T.; Ballings, P.; Coates Palgrave, M. Flora of Zimbabwe: Species Information: Individual Images: Helichrysum nudifolium var. pilosellum. Available online: https://www.zimbabweflora.co.zw/speciesdata/species.php?species_id=159810 (accessed on 11 May 2022).
  68. Mokoka, T.A.; Zimmermann, S.; Julianti, T.; Hata, Y.; Moodley, N.; Cal, M.; Adams, M.; Kaiser, M.; Brun, R.; Koorbanally, N.; et al. In vitro screening of traditional South African malaria remedies against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum. Planta Med. 2011, 77, 1663–1667. [Google Scholar] [CrossRef] [Green Version]
  69. Maroyi, A. A synthesis and a review of medicinal uses, phytochemistry and biological activities of Helichrysum odoratissimum (L.) Sweet. Asian J. Pharm. Clin. Res. 2019, 12, 15–23. [Google Scholar] [CrossRef]
  70. SANBI (South African National Biodiversity Institute). Helichrysum odoratissimum. Available online: http://pza.sanbi.org/Helichrysum-odoratissimum (accessed on 28 February 2022).
  71. Twilley, D.; Kishore, N.; Meyer, D.; Moodley, I.; Kumar, V.; Lall, N. The effect of Helichrysum odoratissimum (L.) sweet on cancer cell proliferation and cytokine production. Int. J. Pharmacogn. Phytochem. Res. 2017, 9, 621–631. [Google Scholar]
  72. Ngagi, J.M.; Ngugi, M.P.; Kibiti, C.M.; Ngeranwa, J.; Njue, W.; Gathumbi, P.; Njabi, E. Hypoglycemic effect of Helichrysum odoratissimum in alloxan induced diabetic mice. J. Pharmacol. 2015, 4, 30–33. [Google Scholar]
  73. Vujić, B.; Vidaković, V.; Jadranin, M.; Novaković, I.; Trifunović, S.; Tešević, V.; Mandić, B. Composition, antioxidant potential, and antimicrobial activity of Helichrysum plicatum DC. various extracts. Plants 2020, 9, 337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Polat, R.; Cakilcioglu, U.; Satıl, F. Traditional uses of medicinal plants in Solhan (Bingöl—Turkey). J. Ethnopharmacol. 2013, 148, 951–963. [Google Scholar] [CrossRef] [PubMed]
  75. POWO. Plants of the World Online. Facilitated by the Royal Botanic Gardens, Kew. Helichrysum plicatum. 2022. Available online: https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:213189-1 (accessed on 28 February 2022).
  76. Eroglu, H.E.; Budak, Ü.M.I.T.; Hamzaoglu, E.; Aksoy, A.; Albayrak, S. In vitro cytotoxic effects of methanol extracts of six Helichrysum taxa used in traditional medicine. Pak. J. Bot. 2010, 42, 3229–3237. [Google Scholar]
  77. Bigović, D.; Šavikin, K.; Janković, T.; Menković, N.; Zdunić, G.; Stanojković, T.; Djurić, Z. Antiradical and cytotoxic activity of different Helichrysum plicatum flower extracts. Nat. Prod. Commun. 2011, 6, 819–822. [Google Scholar] [CrossRef] [Green Version]
  78. Aslan, M.; Orhan, D.D.; Orhan, N.; Sezik, E.; Yesilada, E. In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. J. Ethnopharmacol. 2007, 109, 54–59. [Google Scholar] [CrossRef]
  79. Aydin, T. Secondary metabolites of Helichrysum plicatum DC. subsp. plicatum flowers as strong carbonic anhydrase, cholinesterase and α-glycosidase inhibitors. Z. Naturforsch. C 2020, 75, 153–159. [Google Scholar] [CrossRef]
  80. Deutschländer, M.S.; Lall, N.; van de Venter, M. Plant species used in the treatment of diabetes by South African traditional healers: An inventory. Pharm. Biol. 2009, 47, 348–365. [Google Scholar] [CrossRef]
  81. Serabele, K.; Chen, W.; Tankeu, S.; Combrinck, S.; Veale, C.G.; van Vuuren, S.; Chaudhary, S.K.; Viljoen, A. Comparative chemical profiling and antimicrobial activity of two interchangeably used ‘Imphepho’species (Helichrysum odoratissimum and Helichrysum petiolare). S. Afr. J. Bot. 2021, 137, 117–132. [Google Scholar] [CrossRef]
  82. Sagbo, I.; Mbeng, W. Plants used for cosmetics in the Eastern Cape Province of South Africa: A case study of skin care. Pharmacogn. Rev. 2018, 12, 139–156. [Google Scholar] [CrossRef]
  83. SANBI (South African National Biodiversity Institute). Helichrysum petiolare. Available online: http://opus.sanbi.org/bitstream/20.500.12143/3485/1/Helichrysumpetiolare_PlantzAfrica.pdf (accessed on 28 February 2022).
  84. Aladejana, A.E.; Bradley, G.; Afolayan, A.J. In vitro evaluation of the anti-diabetic potential of Helichrysum petiolare Hilliard & B.L. Burtt using HepG2 (C3A) and L6 cell lines. F1000Research 2021, 9, 1240. [Google Scholar]
  85. Sagbo, I.J.; Otang-Mbeng, W. Anti-proliferative and genotoxic activities of the Helichrysum petiolare Hilliard & BL Burtt. Sci. Pharm. 2020, 88, 49. [Google Scholar]
  86. Akinyede, K.A.; Oyewusi, H.A.; Hughes, G.D.; Ekpo, O.E.; Oguntibeju, O.O. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone Helichrysum petiolare Extract (AAHPE) with Molecular Docking Relevance in Diabetes Mellitus. Molecules 2022, 27, 155. [Google Scholar] [CrossRef] [PubMed]
  87. Dalar, A. Plant Taxa Used in the Treatment of Diabetes in Van Province, Turkey. Int. J. Pharm. Scond. Metab. 2018, 5, 171–185. [Google Scholar] [CrossRef]
  88. Mükemre, M.; Behçet, L.; Çakılcıoğluc, U. Ethnobotanical study on medicinal plants in villages of Çatak (Van-Turkey). J. Ethnopharmacol. 2015, 166, 361–374. [Google Scholar] [CrossRef] [PubMed]
  89. Semenya, S.; Potgieter, M.; Erasmus, L. Ethnobotanical survey of medicinal plants used by Bapedi healers to treat diabetes mellitus in the Limpopo Province, South Africa. J. Ethnopharmacol. 2012, 141, 440–445. [Google Scholar] [CrossRef] [PubMed]
  90. Acet, T.; Ozcan, K.; Zengin, G. An assessment of phenolic profiles, fatty acid compositions, and biological activities of two Helichrysum species: Helichrysum plicatum and Helichrysum chionophilum. J. Food Biochem. 2020, 44, e13128. [Google Scholar] [CrossRef]
  91. Hulley, M.I.; Van Vuuren, S.F.; Sadgrove, N.J.; Van Wyk, B.-E. Antimicrobial activity of Elytropappus rhinocerotis (Asteraceae) against micro-organisms associated with foot odour and skin ailments. J. Ethnopharmacol. 2019, 228, 92–98. [Google Scholar] [CrossRef]
  92. Jadalla, B.M.I.S. Phytochemical and Biological Studies of Helichrysum cymosum. Master’s Thesis, University of the Western Cape, Cape Town, South Africa, 2020. [Google Scholar]
  93. Spínola, V.; Castilho, P.C. Evaluation of Asteraceae herbal extracts in the management of diabetes and obesity. Contribution of caffeoylquinic acids on the inhibition of digestive enzymes activity and formation of advanced glycation end-products (in vitro). Phytochemistry 2017, 143, 29–35. [Google Scholar] [CrossRef]
  94. Jaradat, N.; Qneibi, M.; Hawash, M.; Sawalha, A.; Qtaishat, S.; Hussein, F.; Issa, L. Chemical composition, antioxidant, antiobesity, and antidiabetic effects of Helichrysum sanguineum (L.) Kostel. from Palestine. Arab. J. Sci. Eng. 2021, 46, 41–51. [Google Scholar] [CrossRef]
  95. Les, F.; Venditti, A.; Cásedas, G.; Frezza, C.; Guiso, M.; Sciubba, F.; Serafini, M.; Bianco, A.; Valero, M.S.; López, V. Everlasting flower (Helichrysum stoechas Moench) as a potential source of bioactive molecules with antiproliferative, antioxidant, antidiabetic and neuroprotective properties. Ind. Crops Prod. 2017, 108, 95–302. [Google Scholar] [CrossRef]
  96. Van Vuuren, S.F.; Viljoen, A.M.; van Zyl, R.L.; Van Heerden, F.R.; Başer, K.H.C. The antimicrobial, antimalarial and toxicity profiles of helihumulone, leaf essential oil and extracts of Helichrysum cymosum (L.) D. Don subsp. cymosum. S. Afr. J. Bot. 2006, 72, 287–290. [Google Scholar] [CrossRef] [Green Version]
  97. Gouveia-Figueira, S.C.; Gouveia, C.A.; Carvalho, M.J.; Rodrigues, A.I.; Nording, M.L.; Castilho, P.C. Antioxidant capacity, cytotoxicity and antimycobacterial activity of madeira archipelago endemic Helichrysum dietary and medicinal plants. Antioxidants 2014, 3, 713–729. [Google Scholar] [CrossRef] [PubMed]
  98. Erolue, E.H.; Hamzaolu, E.; Aksoy, A.; Budak, Ü.; Özkul, Y. In vitro genotoxic effects of four Helichrysum species in human lymphocytes cultures. Biol. Res. 2010, 43, 177–182. [Google Scholar] [CrossRef]
  99. Zengin, G.; Cvetanović, A.; Gašić, U.; Tešić, Z.; Stupar, A.; Bulut, B.; Sinan, K.I.; Uysal, S.; Picot-Allain, M.C.N.; Mahomoodally, M.F. A comparative exploration of the phytochemical profiles and bio-pharmaceutical potential of Helichrysum stoechas subsp. barrelieri extracts obtained via five extraction techniques. Process Biochem. 2020, 91, 113–125. [Google Scholar] [CrossRef]
Plants 11 01386 g001 550
Figure 1. Several action sites of conventional medicines (current antidiabetic drugs).
Figure 1. Several action sites of conventional medicines (current antidiabetic drugs).
Plants 11 01386 g001
Plants 11 01386 g002 550
Figure 2. Secondary metabolites isolated from Helichrysum species with antidiabetic activity. The numbers 1–12 correspond to the compounds reported in Table 2.
Figure 2. Secondary metabolites isolated from Helichrysum species with antidiabetic activity. The numbers 1–12 correspond to the compounds reported in Table 2.
Plants 11 01386 g002
Plants 11 01386 g003 550
Figure 3. H. arenarium. Source: POWO [35].
Figure 3. H. arenarium. Source: POWO [35].
Plants 11 01386 g003
Plants 11 01386 g004 550
Figure 4. H. aureum. Source: SANBI [39].
Figure 4. H. aureum. Source: SANBI [39].
Plants 11 01386 g004
Plants 11 01386 g005 550
Figure 5. H. caespititium. Source: Flora of Zimbabwe [44].
Figure 5. H. caespititium. Source: Flora of Zimbabwe [44].
Plants 11 01386 g005
Plants 11 01386 g006 550
Figure 6. H. graveolens. Source: POWO [47].
Figure 6. H. graveolens. Source: POWO [47].
Plants 11 01386 g006
Plants 11 01386 g007 550
Figure 7. H. gymnocomum. Source: FOSTER [53].
Figure 7. H. gymnocomum. Source: FOSTER [53].
Plants 11 01386 g007
Plants 11 01386 g008 550
Figure 8. H. italicum. Source: American Botanical Council [56].
Figure 8. H. italicum. Source: American Botanical Council [56].
Plants 11 01386 g008
Plants 11 01386 g009 550
Figure 9. H. nudifolium. Source: Flora of Zimbabwe [67].
Figure 9. H. nudifolium. Source: Flora of Zimbabwe [67].
Plants 11 01386 g009
Plants 11 01386 g010 550
Figure 10. H. odoratissimum. Source: SANBI [70].
Figure 10. H. odoratissimum. Source: SANBI [70].
Plants 11 01386 g010
Plants 11 01386 g011 550
Figure 11. H. plicatum. Source: POWO [75].
Figure 11. H. plicatum. Source: POWO [75].
Plants 11 01386 g011
Plants 11 01386 g012 550
Figure 12. H. petiolare. Source: SANBI [83].
Figure 12. H. petiolare. Source: SANBI [83].
Plants 11 01386 g012
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Akinfenwa, A.O.; Sagbo, I.J.; Makhaba, M.; Mabusela, W.T.; Hussein, A.A. Helichrysum Genus and Compound Activities in the Management of Diabetes Mellitus. Plants 2022, 11, 1386. https://doi.org/10.3390/plants11101386

AMA Style

Akinfenwa AO, Sagbo IJ, Makhaba M, Mabusela WT, Hussein AA. Helichrysum Genus and Compound Activities in the Management of Diabetes Mellitus. Plants. 2022; 11(10):1386. https://doi.org/10.3390/plants11101386

Chicago/Turabian Style

Akinfenwa, Akeem O., Idowu J. Sagbo, Masixole Makhaba, Wilfred T. Mabusela, and Ahmed A. Hussein. 2022. "Helichrysum Genus and Compound Activities in the Management of Diabetes Mellitus" Plants 11, no. 10: 1386. https://doi.org/10.3390/plants11101386

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop